Heard through a mate of a mate of a mate who received the note (penned in late July) from Southern Cross Equities that they were very bullish on Biosignal and had a valuation target of $0.77 per share base case and around $1.80 per share optimistic case.
Haven't been able to get any more details than that and note that the recent announcement was post the latest BOS announcement.
However, very encouraging that a well respected firm like SCE has such a valuation. I'd be happy with $0.77 per share, let alone $1.80!
Big 6 to 12 months ahead for BOS.
Add to My Watchlist
What is My Watchlist?